高血圧性HFpEF検出における心室ひずみよりも優れた心房ひずみ
Zhen Wang1, Yuncheng Li1, Yong Cheng1
1Department of Radiology, The First Affiliated Hospital of Anhui Medical University; Research Center of Clinical Medical Imaging; Anhui Province Clinical Image Quality Control Center, Hefei, China (Z.W., Y.L., Y.C., Y.Y., X.L.).
Background:
Heart failure with preserved ejection fraction (HFpEF) accounts for ≈50% of heart failure, and hypertension often coexists. Although strain imaging detects subclinical dysfunction, the relative diagnostic value of left atrial (LA) versus left ventricular (LV) strain for identifying hypertensive HFpEF remains uncertain. We compared LA and LV strain using cardiac MR feature tracking to determine optimal markers for HFpEF detection.
Methods:
A single-center, retrospective study included 191 participants: 71 with HFpEF and hypertension (HFpEF-HTN), 60 with essential hypertension, and 60 controls who underwent CMR. Cardiac MR feature tracking quantified LV global strains and strain rates, and LA reservoir (εs), conduit (εe), and booster pump (εa) strain with corresponding strain rates. One-way ANOVA compared groups, logistic regression identified HFpEF-HTN predictors, and receiver operating characteristic analysis with area under the curve assessed diagnostic accuracy.
Results:
All LA strain parameters showed stepwise impairment from controls to hypertension to HFpEF-HTN (all P<0.05). LV global strains decreased in HFpEF-HTN versus controls, while hypertension exhibited only reduced global longitudinal strain (all P<0.05). LA parameters demonstrated superior discriminatory performance over LV parameters. εs best distinguished HFpEF-HTN from hypertension (area under the curve, 0.802 [95% CI, 0.724-0.867]), while εe best discriminated hypertension from controls (area under the curve, 0.892 [95% CI, 0.823-0.942]).
Conclusions:
LA strain parameters, particularly εs, provided superior diagnostic performance over LV strain in distinguishing HFpEF-HTN from hypertension. These findings support the potential role of LA strain as a sensitive imaging biomarker for detecting HFpEF-HTN. Prospective validation is needed before clinical implementation.
さらに関連する動画
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
